Literature DB >> 27135144

A Novel Free Flap Monitoring System Using Tissue Oximetry with Text Message Alerts.

Joseph A Ricci1, Christina R Vargas1, Samuel J Lin1, Adam M Tobias1, Amir H Taghinia2, Bernard T Lee1.   

Abstract

Background The time to detection of vascular compromise is a significant predictor of free flap salvage outcomes as early reexploration improves salvage rates. Continuous transcutaneous near-infrared tissue oximetry is an objective, quantitative method of detecting flap vascular compromise and has been shown to allow earlier reexploration and higher salvage rates than clinical assessment alone. We designed a novel text messaging system to improve communication using tissue oximetry monitoring. Methods A retrospective review was performed of a prospectively collected database of all microsurgical breast reconstructions from 2008 to 2015. A novel text messaging system was introduced in 2013 and programmed to send text messages alert when the tissue oximetry readings suggested potential flap compromise based on established thresholds. Patient demographics and complications, including rate of reexploration and flap loss were assessed. Results There were 900 autologous microsurgical breast free flaps during the study period: 614 were monitored with standard clinical monitoring and tissue oximetry compared with 286 flaps with the additional text messaging system. There were 27 unplanned returns to the operating room in the tissue oximetry group and 5 in the text messaging group with 1 complete flap loss in each group. Reexploration occurred sooner as a result of these text message alerts (17.5 vs. 26.6 hours postoperatively), however, it did not achieve statistical significance. Conclusions We were able to demonstrate the use of a novel text messaging system for tissue oximetry. This alert system shows promise in identifying impending flap loss with rapid notification of the surgical team. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27135144     DOI: 10.1055/s-0036-1582264

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  6 in total

Review 1.  Flap Monitoring Using Transcutaneous Oxygen or Carbon Dioxide Measurements.

Authors:  Sameer H Halani; Austin S Hembd; Xingchen Li; Ben Kirby; Courtney C Beard; Nicholas T Haddock; Thomas M Suszynski
Journal:  J Hand Microsurg       Date:  2020-11-16

2.  The Impact of Race on Perioperative and Patient-Reported Outcomes following Autologous Breast Reconstruction.

Authors:  Sabine Oskar; Jonas A Nelson; Madeleine E V Hicks; Kenneth P Seier M S; Kay See Tan; Jacqueline J Chu; Scott West; Robert J Allen; Andrea V Barrio; Evan Matros; Anoushka M Afonso
Journal:  Plast Reconstr Surg       Date:  2022-01-01       Impact factor: 5.169

3.  The National Surgical Quality Improvement Program 30-Day Challenge: Microsurgical Breast Reconstruction Outcomes Reporting Reliability.

Authors:  Austin D Chen; Parisa Kamali; Anmol S Chattha; Alexandra Bucknor; Justin B Cohen; Patrick P Bletsis; Renata Flecha-Hirsch; Adam M Tobias; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-03-06

4.  Enabling Remote Monitoring Using Free Apps and Smart Devices for a Free-Flap Adjunct Monitor.

Authors:  James C Yuen
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-09-21

5.  Hyperspectral Imaging (HSI) as a new diagnostic tool in free flap monitoring for soft tissue reconstruction: a proof of concept study.

Authors:  Lukas H Kohler; Hannes Köhler; Simon Kohler; Stefan Langer; Rima Nuwayhid; Ines Gockel; Nick Spindler; Georg Osterhoff
Journal:  BMC Surg       Date:  2021-04-30       Impact factor: 2.102

Review 6.  Near-Infrared Spectroscopy (NIRS) versus Hyperspectral Imaging (HSI) to Detect Flap Failure in Reconstructive Surgery: A Systematic Review.

Authors:  Anouk A M A Lindelauf; Alexander G Saelmans; Sander M J van Kuijk; René R W J van der Hulst; Rutger M Schols
Journal:  Life (Basel)       Date:  2022-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.